Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|February 13, 2023
Orphan drugs' clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursementHans-Georg Eichler, Michael Kossmeier, Markus Zeitlinger, et al.
Clinical Trials (London, England)|March 29, 2024
Challenges in conducting efficacy trials for new COVID-19 vaccines in developed countriesRafael Dal-Ré, Emmanuel Bottieau, Odile Launay, et al.
Clinical Pharmacology and Therapeutics|October 30, 2021
Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-PredictHans-Georg Eichler, Mark Trusheim, Brigitte Schwarzer-Daum, et al.
Clinical Pharmacology and Therapeutics|October 2, 2019
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent ValidationHans-Georg Eichler, Franz Koenig, Peter Arlett, et al.
Clinical Pharmacology and Therapeutics|October 16, 2020
Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor MythHans-Georg Eichler, Francesco Pignatti, Brigitte Schwarzer-Daum, et al.
The Lancet. Infectious Diseases|May 21, 2021
Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunitiesRafael Dal-Ré, Linda-Gail Bekker, Christian Gluud, et al.
Frontiers in Medicine|September 13, 2021
Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit-The EU Regulator's PerspectiveMaria E Sheean, Frauke Naumann-Winter, Giuseppe Capovilla, et al.
Pageof 1